Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Autoriserede Fysioterapeuter Aarhus Fysioterapi ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/8 2023 2023/8 2024 2024/8 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   1.6% 1.6% 2.9% 1.6% 3.7% 3.0% 6.9% 6.9%   Credit score (0-100)   77 75 56 75 51 58 35 35   Credit rating   A A BBB A BBB BBB BBB BBB   Credit limit (kDKK)   20.4 15.6 0.0 16.9 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/8 2023 2023/8 2024 2024/8 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,736 2,749 2,863 5,314 7,592 8,121 0.0 0.0   EBITDA   1,332 1,119 551 2,691 1,769 822 0.0 0.0   EBIT   914 702 109 2,250 1,030 37.2 0.0 0.0   Pre-tax profit (PTP)   1,276.8 672.5 -25.5 2,185.3 780.6 308.0 0.0 0.0   Net earnings   995.9 524.6 -41.8 1,721.1 626.0 391.6 0.0 0.0   Pre-tax profit without non-rec. items   1,277 673 -25.5 2,185 781 308 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/8 2023 2023/8 2024 2024/8 2025e N/A 2026e N/A Tangible assets total   46.7 30.2 816 2,300 2,368 2,160 0.0 0.0   Shareholders equity total   6,608 6,232 2,841 4,562 1,188 979 879 879   Interest-bearing liabilities   0.0 0.0 2,117 2,522 2,783 3,623 3,378 3,378   Balance sheet total (assets)   8,230 7,750 6,259 8,669 8,152 8,717 4,257 4,257   Net Debt   -314 -390 2,101 2,488 2,739 3,550 3,378 3,378     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/8 2023 2023/8 2024 2024/8 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,736 2,749 2,863 5,314 7,592 8,121 0.0 0.0   Gross profit growth   -9.1% 0.4% 4.1% 85.6% 42.9% 7.0% -100.0% 0.0%   Employees   3 3 3 6 13 19 0 0   Employee growth %   -25.0% 0.0% 0.0% 100.0% 116.7% 46.2% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   8,230 7,750 6,259 8,669 8,152 8,717 4,257 4,257   Balance sheet change%   4.6% -5.8% -19.2% 38.5% -6.0% 6.9% -51.2% 0.0%   Added value   1,332.0 1,118.7 551.3 2,691.1 1,471.1 821.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -836 -833 -57 400 -1,030 632 -2,160 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/8 2023 2023/8 2024 2024/8 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   33.4% 25.5% 3.8% 42.3% 13.6% 0.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   15.9% 8.4% 1.5% 30.1% 13.3% 9.8% 0.0% 0.0%   ROI %   17.0% 9.1% 1.7% 33.1% 17.8% 16.6% 0.0% 0.0%   ROE %   15.4% 8.2% -0.9% 46.5% 21.8% 36.1% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/8 2023 2023/8 2024 2024/8 2025e N/A 2026e N/A Equity ratio %   80.3% 80.4% 45.4% 52.6% 14.6% 11.2% 20.7% 20.7%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -23.5% -34.9% 381.2% 92.4% 154.8% 432.1% 0.0% 0.0%   Gearing %   0.0% 0.0% 74.5% 55.3% 234.3% 370.0% 384.2% 384.2%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 12.7% 2.8% 12.7% 16.1% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/8 2023 2023/8 2024 2024/8 2025e N/A 2026e N/A Quick Ratio   2.6 5.5 0.8 0.9 0.3 0.4 0.0 0.0   Current Ratio   2.6 5.5 0.8 0.9 0.3 0.4 0.0 0.0   Cash and cash equivalent   313.6 390.3 15.9 34.3 43.8 73.2 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/8 2023 2023/8 2024 2024/8 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   983.8 2,884.6 -274.6 -53.6 -3,131.9 -3,372.0 -1,689.1 -1,689.1   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/8 2023 2023/8 2024 2024/8 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   444 373 184 449 113 43 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   444 373 184 449 136 43 0 0   EBIT / employee   305 234 36 375 79 2 0 0   Net earnings / employee   332 175 -14 287 48 21 0 0